These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7915990)
1. Comparison of [11C]diprenorphine and [11C]carfentanil in vivo binding to opiate receptors in man using a dual detector system. Villemagne VL; Frost JJ; Dannals RF; Lever JR; Tanada S; Natarajan TK; Wilson AA; Ravert HT; Wagner HN Eur J Pharmacol; 1994 May; 257(1-2):195-7. PubMed ID: 7915990 [TBL] [Abstract][Full Text] [Related]
2. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography. Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414 [TBL] [Abstract][Full Text] [Related]
3. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Mayberg HS; Sadzot B; Meltzer CC; Fisher RS; Lesser RP; Dannals RF; Lever JR; Wilson AA; Ravert HT; Wagner HN Ann Neurol; 1991 Jul; 30(1):3-11. PubMed ID: 1656846 [TBL] [Abstract][Full Text] [Related]
4. 3H-diprenorphine is selective for mu opiate receptors in vivo. Frost JJ; Smith AC; Wagner HN Life Sci; 1986 Apr; 38(17):1597-606. PubMed ID: 3010021 [TBL] [Abstract][Full Text] [Related]
5. Naloxone displacement at opioid receptor sites measured in vivo in the human brain. Melichar JK; Nutt DJ; Malizia AL Eur J Pharmacol; 2003 Jan; 459(2-3):217-9. PubMed ID: 12524149 [TBL] [Abstract][Full Text] [Related]
9. Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system. Kim S; Wagner HN; Villemagne VL; Kao PF; Dannals RF; Ravert HT; Joh T; Dixon RB; Civelek AC J Nucl Med; 1997 Nov; 38(11):1726-31. PubMed ID: 9374341 [TBL] [Abstract][Full Text] [Related]
10. Imaging opiate receptors in the human brain by positron tomography. Frost JJ; Wagner HN; Dannals RF; Ravert HT; Links JM; Wilson AA; Burns HD; Wong DF; McPherson RW; Rosenbaum AE J Comput Assist Tomogr; 1985; 9(2):231-6. PubMed ID: 2982931 [TBL] [Abstract][Full Text] [Related]
11. Interaction of peptides and morphine-like narcotic analgesics with specifically labelled mu- and delta-opiate receptor binding sites. Hermans B; Gommeren W; De Potter WP; Leysen JE Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):317-9. PubMed ID: 6136260 [No Abstract] [Full Text] [Related]
12. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography. Sadzot B; Price JC; Mayberg HS; Douglass KH; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Feldman MA J Cereb Blood Flow Metab; 1991 Mar; 11(2):204-19. PubMed ID: 1847703 [TBL] [Abstract][Full Text] [Related]
13. In vitro binding properties of 3H-sufentanil, a superior ligand for the mu-opiate receptor. Leysen JE; Gommeren W Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):287-9. PubMed ID: 6131653 [No Abstract] [Full Text] [Related]
14. Preparation and biodistribution in mice of [11C]carfentanil: a radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography. Saji H; Tsutsumi D; Magata Y; Iida Y; Konishi J; Yokoyama A Ann Nucl Med; 1992 Feb; 6(1):63-7. PubMed ID: 1325823 [TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of four types of opioid binding sites in rat brain. Sadée W; Richards ML; Grevel J; Rosenbaum JS Life Sci; 1983; 33 Suppl 1():187-9. PubMed ID: 6141486 [TBL] [Abstract][Full Text] [Related]
16. The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors. Xu W; Chen C; Huang P; Li J; de Riel JK; Javitch JA; Liu-Chen LY Biochemistry; 2000 Nov; 39(45):13904-15. PubMed ID: 11076532 [TBL] [Abstract][Full Text] [Related]
17. Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography. Frost JJ; Douglass KH; Mayberg HS; Dannals RF; Links JM; Wilson AA; Ravert HT; Crozier WC; Wagner HN J Cereb Blood Flow Metab; 1989 Jun; 9(3):398-409. PubMed ID: 2541148 [TBL] [Abstract][Full Text] [Related]
18. The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys. Scott PJH; Koeppe RA; Shao X; Rodnick ME; Sowa AR; Henderson BD; Stauff J; Sherman PS; Arteaga J; Carlo DJ; Moss RB Molecules; 2020 Mar; 25(6):. PubMed ID: 32192089 [TBL] [Abstract][Full Text] [Related]
19. Opiate receptor binding-effect relationship: sufentanil and etorphine produce analgesia at the mu-site with low fractional receptor occupancy. Rosenbaum JS; Holford NH; Sadée W Brain Res; 1984 Jan; 291(2):317-24. PubMed ID: 6320962 [TBL] [Abstract][Full Text] [Related]
20. Discrimination of three types of opioid binding sites in rat brain in vivo. Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]